FUQIX | VIGRX | FUQIX / VIGRX | |
Total Expense Ratio | 0.11 | 0.17 | 65% |
Annual Report Gross Expense Ratio | 0.11 | 0.17 | 65% |
Fund Existence | 10 years | 33 years | - |
Gain YTD | -6.485 | -12.154 | 53% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.8B | 261B | 7% |
Annual Yield % from dividends | 0.98 | 0.39 | 254% |
Returns for 1 year | -2.18 | 8.89 | -25% |
Returns for 3 years | 22.15 | 37.20 | 60% |
Returns for 5 years | 56.52 | 105.69 | 53% |
Returns for 10 years | N/A | 230.06 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 18.66 | 0.77 | +4.30% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
VIOO | 92.25 | 1.85 | +2.05% |
Vanguard S&P Small-Cap 600 ETF | |||
EDIV | 35.93 | 0.42 | +1.18% |
SPDR® S&P Emerging Markets Dividend ETF | |||
DEHP | 25.12 | 0.24 | +0.96% |
Dimensional Em Mkts High Prof ETF | |||
NVD | 29.40 | -2.31 | -7.28% |
GraniteShares 2x Short NVDA Daily ETF |